Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Onco-Innovations Ltd. ( (TSE:ONCO) ) has issued an announcement.
Onco-Innovations Limited has appointed Dr. Michael Lock to its Scientific and Clinical Advisory Board, enhancing its expertise in clinical trial design and multidisciplinary cancer care. This strategic move is expected to bolster the company’s development of novel therapies, including its PNKP inhibitor program, and strengthen its clinical and translational research initiatives.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based company specializing in oncology, focusing on cancer research and treatment. The company is dedicated to the prevention and treatment of cancer through pioneering research and innovative solutions, and it holds an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 85,083
Technical Sentiment Signal: Strong Sell
For a thorough assessment of ONCO stock, go to TipRanks’ Stock Analysis page.